Physician profile
Bryan D Cogar
NPI 1063555274
$13,587.12
in general payments reported to CMS, 2019-2025
32 companies · $3,700 in 2025
The $3,700 reported for 2025 was more than what 79% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,573 · 2020: $599 · 2021: $1,787 · 2022: $2,078 · 2023: $1,204 · 2024: $1,647 · 2025: $3,700.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,821 · Travel and Lodging: $1,730.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,820.51 |
| Travel and Lodging | $1,729.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $2,509.74 | 2019-2025 | Triclip, Absolute Pro, Amplatzer Amulet |
| Edwards Lifesciences Corporation | $2,139.75 | 2020-2025 | Evoque, Pascal |
| Boston Scientific Corporation | $2,049.09 | 2019-2025 | Avvigo Guidance System, Watchman, Watchman Flx |
| Medtronic Vascular, INC. | $1,381.86 | 2019-2020 | |
| Medtronic, INC. | $1,282.74 | 2021-2025 | Corevalve Evolut R, Symplicity G3, Hawkone |
| Abiomed | $832.51 | 2019-2025 | |
| Shockwave Medical, INC | $810.43 | 2020-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $471.71 | 2019-2025 | Lifevest |
| Asahi Intecc USA, INC. | $223.21 | 2019-2024 | Peripheral Vascular |
| Novartis Pharmaceuticals Corporation | $203.78 | 2019-2025 | |
| Actelion Pharmaceuticals US, INC. | $203.40 | 2021-2023 | Opsumit |
| Penumbra, INC. | $180.99 | 2020-2022 | |
| Atricure, INC. | $179.86 | 2021 | |
| Janssen Pharmaceuticals, INC | $168.40 | 2021-2023 | Xarelto |
| E.R. Squibb & Sons, L.L.C. | $155.81 | 2019-2023 | Camzyos |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inari Medical, INC. | $112.97 | 2021-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Kestra Medical Technology Services, INC. | $99.97 | 2022-2025 | Assure Wcd |
| Merck Sharp & Dohme LLC | $93.02 | 2022-2024 | Winrevair |
| Boehringer Ingelheim Pharmaceuticals, INC. | $90.52 | 2021-2023 | Jardiance |
| Philips North America LLC | $74.01 | 2019-2025 | Igt Devices Undivided |
| Astrazeneca Pharmaceuticals LP | $72.33 | 2019-2024 | Farxiga |
| Amgen INC. | $57.65 | 2021-2024 | Repatha |
| Cvrx, INC. | $33.62 | 2022 | |
| Cardiovascular Systems INC. | $28.19 | 2019 | |
| Angiodynamics, INC. | $18.55 | 2021 | |
| Novo Nordisk INC | $18.51 | 2022 | |
| Lexicon Pharmaceuticals, INC. | $17.08 | 2024 | |
| Regeneron Healthcare Solutions, INC. | $15.90 | 2019 | |
| Irhythm Technologies, INC. | $15.88 | 2019 | |
| Pfizer INC. | $15.59 | 2022 | |
| Cook Medical LLC | $15.54 | 2019 | |
| Bardy Diagnostics, INC. | $14.51 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bryan Cogar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.